JOHNSON & JOHNSON

Trading Ideas Johnson & Johnson Deutsche Boerse AG

Equities

JNJ

US4781601046

Real-time Estimate Tradegate Other stock markets 02:02:23 01/07/2024 pm IST			5-day change	1st Jan Change
136.2 ^EUR	-0.41%		-2.26%	-4.26%

28/06	Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial	MT
28/06	J&J Unit's Rybrevant Combo Gets EU Approval	MT

Trading Ideas

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JOHNSON & JOHNSON :An end to the technical rebound lies ahead	27/19/27
JOHNSON & JOHNSON :The underlying trend is to the upside	12/17/12
JOHNSON & JOHNSON :Expect the comeback of a strong trend	10/17/10
JOHNSON & JOHNSON :Buying pressure	22/16/22
JOHNSON & JOHNSON :A good level to buy	12/16/12
JOHNSON & JOHNSON :Towards historic highs	26/12/26
JOHNSON & JOHNSON :Beginning of a bearish movement	26/12/26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 11:00 pm IST

Protect and grow your investments with the help of our experts

Securing my Investments

fermer